Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Viasat (VSAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Viasat — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.24 (market cap $2.28B), while Viasat trades at $69 (market cap $9.76B). The key difference: Viasat is far larger — about 4.3× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is more actively traded (3,128,960 versus 1,739,997). Which is the better fit depends on your goals.
| SLS | VSAT | |
|---|---|---|
Market Cap | $2.28B | $9.76B |
Volume | 3,128,960 | 1,739,997 |
Sector | Health | Technology |
52-Week High | $15.46 | $89.81 |
52-Week Low | $1.39 | $30.35 |
Enterprise Value | $2.15B | $14.95B |
Typical Hold Time | — | 10 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Viasat
Viasat provides satellite communications and connectivity services for aviation, maritime, government, enterprise, and consumer markets. Its network combines satellite and ground infrastructure to deliver connectivity in remote and mobile environments.
Read more on VSAT →
